blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0675730

EP0675730 - THERAPEUTIC COMBINATION CONTAINING INTERFERON [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.01.2002
Database last updated on 30.03.2026
Most recent event   Tooltip26.12.2003Lapse of the patent in a contracting state
New state(s): GR		published on 11.02.2004  [2004/07]
Applicant(s)For all designated states
THE WELLCOME FOUNDATION LIMITED
Glaxo Wellcome House, Berkeley Avenue Greenford
Middlesex UB6 0NN / GB
[N/P]
Former [1997/42]For all designated states
THE WELLCOME FOUNDATION LIMITED
Glaxo Wellcome House, Berkeley Avenue
Greenford, Middlesex UB6 0NN / GB
Former [1995/41]For all designated states
THE WELLCOME FOUNDATION LIMITED
Unicorn House 160 Euston Road
London NW1 2BP / GB
Inventor(s)01 / PRIETO VALTUENA, Jesus
Tudela, 22-4o
E- Pamplona / ES
02 / BELOQUI RUIZ, Oscar
Travesia Monasterio Urdax, 2-5oD
E-Pamplona / ES
[1995/41]
Representative(s)Stott, Michael John, et al
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [1995/41]Stott, Michael John, et al
The Wellcome Foundation Limited Group Patents & Agreements Langley Court
Beckenham Kent BR3 3BS / GB
Application number, filing date94902910.220.12.1993
[1995/41]
WO1993GB02600
Priority number, dateGB1992002672922.12.1992         Original published format: GB 9226729
[1995/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9414473
Date:07.07.1994
Language:EN
[1994/15]
Type: A1 Application with search report 
No.:EP0675730
Date:11.10.1995
Language:EN
The application published by WIPO in one of the EPO official languages on 07.07.1994 takes the place of the publication of the European patent application.
[1995/41]
Type: B1 Patent specification 
No.:EP0675730
Date:14.03.2001
Language:EN
[2001/11]
Search report(s)International search report - published on:EP07.07.1994
ClassificationIPC:A61K38/21, A61K38/06
[1999/17]
CPC:
A61K38/21 (EP,US); A61B17/3417 (EP,US); A61B17/3476 (EP,US);
A61B17/3496 (EP,US); A61B18/1487 (EP,US); A61K31/195 (EP,US);
A61K38/063 (EP,US); A61K38/212 (EP,US); A61K45/06 (EP,US);
A61P1/16 (EP); A61P31/12 (EP); A61P43/00 (EP);
A61B17/320725 (EP,US); A61B17/32075 (EP,US); A61B17/3211 (EP,US);
A61B17/3474 (EP,US); A61B2018/0019 (EP,US); A61M13/003 (EP,US) (-)
C-Set:
A61K38/212, A61K2300/00 (US,EP);
A61K38/212, A61K31/195 (US,EP);
A61K38/212, A61K38/063 (EP,US);
A61K38/21, A61K2300/00 (US,EP);
A61K38/21, A61K31/195 (EP,US);
A61K38/21, A61K38/06 (EP,US)
(-)
Former IPC [1995/41]A61K37/66
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1995/41]
TitleGerman:THERAPEUTISCHES KOMBINATIONSPRÄPARAT ENTHALTEND INTERFERON[2001/11]
English:THERAPEUTIC COMBINATION CONTAINING INTERFERON[1995/41]
French:ASSOCIATION THERAPEUTIQUE CONTENANT L'INTERFERON[1995/41]
Former [1995/41]Therapeutische Interferon enthaltende Zusammensetzung
Entry into regional phase15.05.1995National basic fee paid 
15.05.1995Designation fee(s) paid 
15.05.1995Examination fee paid 
Examination procedure24.05.1994Request for preliminary examination filed
International Preliminary Examining Authority: EP
15.05.1995Examination requested  [1995/41]
22.12.1995Despatch of a communication from the examining division (Time limit: M06)
17.06.1996Reply to a communication from the examining division
25.11.1996Despatch of a communication from the examining division (Time limit: M04)
27.03.1997Reply to a communication from the examining division
06.05.1997Despatch of a communication from the examining division (Time limit: M02)
22.05.1997Reply to a communication from the examining division
22.12.1997Despatch of a communication from the examining division (Time limit: M04)
22.04.1998Reply to a communication from the examining division
20.03.2000Despatch of communication of intention to grant (Approval: Yes)
22.09.2000Communication of intention to grant the patent
05.12.2000Fee for grant paid
05.12.2000Fee for publishing/printing paid
Opposition(s)15.12.2001No opposition filed within time limit [2002/10]
Fees paidRenewal fee
05.10.1995Renewal fee patent year 03
11.12.1996Renewal fee patent year 04
12.12.1997Renewal fee patent year 05
11.12.1998Renewal fee patent year 06
09.12.1999Renewal fee patent year 07
13.12.2000Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT14.03.2001
BE14.03.2001
CH14.03.2001
GR14.03.2001
LI14.03.2001
NL14.03.2001
DK14.06.2001
SE14.06.2001
PT15.06.2001
[2004/07]
Former [2003/45]AT14.03.2001
BE14.03.2001
CH14.03.2001
LI14.03.2001
NL14.03.2001
DK14.06.2001
SE14.06.2001
PT15.06.2001
Former [2003/08]AT14.03.2001
BE14.03.2001
CH14.03.2001
LI14.03.2001
NL14.03.2001
SE14.06.2001
PT15.06.2001
Former [2002/26]AT14.03.2001
BE14.03.2001
CH14.03.2001
LI14.03.2001
SE14.06.2001
PT15.06.2001
Former [2002/13]AT14.03.2001
BE14.03.2001
CH14.03.2001
LI14.03.2001
SE14.06.2001
Former [2002/10]AT14.03.2001
BE14.03.2001
SE14.06.2001
Former [2002/05]BE14.03.2001
SE14.06.2001
Former [2002/03]BE14.03.2001
Cited inInternational search[A]   PIETRO GHEZZI ET AL.: "ROLE OF REACTIVE OXYGEN INTERMEDIATES IN THE INTERFERON-MEDIATED DEPRESSION OF HEPATIC DRUG METABOLISM AND PROTECTIVE EFFECT OF N-ACETYLCYSTEINE IN MICE.", CANCER RESEARCH, vol. 45, no. 8, August 1985 (1985-08-01), pages 3444 - 3447 [A] 1,7,10,11,17,19,20,27,31,37,39 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.